Nuzenio

Endpoint

Endpoint news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 17 publisher sources 100/100 entity strength

Latest news

CoinMarketCap Expands Its Pro API With Real-World Asset Data Endpoints - HackerNoonHackerNoon · Fri, 07 Aug 2026 22:00:50 GMTTPx Expands Managed Security Portfolio with SentinelOne-Powered Managed Endpoint Security - Telecom Reseller / Technology Reseller NewsTelecom Reseller / Technology Reseller News · Fri, 07 Aug 2026 19:42:42 GMTEndpoint Security and Network Monitoring News for the Week of August 7th: SentinelOne, Arctic Wolf, ServiceNow, and More - Solutions ReviewSolutions Review · Fri, 07 Aug 2026 16:27:32 GMTFDA to hold adcomm for Grail cancer test that failed in large, randomized trial - Endpoints NewsEndpoints News · Fri, 07 Aug 2026 16:08:00 GMTOral TYK2 Inhibitor Socrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Trial - Dermatology TimesDermatology Times · Fri, 07 Aug 2026 16:04:43 GMTBioMarin discontinues rare disease drug; CSL and Arcturus split up - Endpoints NewsEndpoints News · Fri, 07 Aug 2026 15:08:00 GMTBioMarin axes $270M asset after missing phase 3 endpoint - Fierce BiotechFierce Biotech · Fri, 07 Aug 2026 13:10:41 GMTScalefusion mid-year platform update: Unified Endpoint Management, identity, and security enhancements - ETCISO.inETCISO.in · Fri, 07 Aug 2026 08:20:26 GMT

Timeline

Fri, 07 Aug 2026 22:00:50 GMTCoinMarketCap Expands Its Pro API With Real-World Asset Data Endpoints - HackerNoon
Fri, 07 Aug 2026 19:42:42 GMTTPx Expands Managed Security Portfolio with SentinelOne-Powered Managed Endpoint Security - Telecom Reseller / Technology Reseller News
Fri, 07 Aug 2026 16:27:32 GMTEndpoint Security and Network Monitoring News for the Week of August 7th: SentinelOne, Arctic Wolf, ServiceNow, and More - Solutions Review
Fri, 07 Aug 2026 16:08:00 GMTFDA to hold adcomm for Grail cancer test that failed in large, randomized trial - Endpoints News
Fri, 07 Aug 2026 16:04:43 GMTOral TYK2 Inhibitor Socrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Trial - Dermatology Times
Fri, 07 Aug 2026 15:08:00 GMTBioMarin discontinues rare disease drug; CSL and Arcturus split up - Endpoints News

Related explainers

CybersecurityCybersecurity stories explain incidents, vulnerabilities, affected organizations, user risk, patches, and accountability.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Endpoint.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

17 distinct publisher/source names are currently connected to this entity page.